Search results
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 4 hours agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Top Stock Movers Now: Moderna, Wayfair, Peloton Interactive, and More
Investopedia· 15 hours agoThe Dow, S&P 500, and Nasdaq all rose. Moderna (MRNA) shares advanced after the vaccine maker...
New vaccine triggers body to fight deadly brain tumors
WFMZ Eastern Pennsylvania and Western New Jersey· 1 day agoA new personalized cancer jab triggers a "fierce" immune response to fight deadly brain tumors, say...
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook - GSK (NYSE:GSK)
Benzinga· 1 day agoVaccines’ sales increased 16% at constant currency to 2.28 billion Pounds, reflecting U.S. demand...
Why are nearly half of all recent biotech RNA alliances in Asia-Pacific betting big on...
BioPharma-Reporter· 2 days agoAlmost half of all strategic alliances focused on RNA therapies over the last five years in the...
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
Zacks· 3 days agoBioNTech’s top line currently comprises sales of its mRNA-based COVID-19 vaccine, Comirnaty, developed in partnership ...
Study identifies immunity threshold for protection against COVID-19 in children
Medical Xpress· 2 days agoAll participants received two doses of 10mcg Pfizer/BioNTech mRNA COVID-19 vaccination, 21 days apart. The team followed up with the ...
Man receives world’s first melanoma vaccine — trial underway
NY Post via Yahoo News· 6 days agoThe Phase 3 trial hopes to recruit 1,100 people. The vaccine, called mRNA-4157 (V940) works...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga· 3 hours agoMerck reported improvement in cancer patients receiving its Keytruda regimen. Enrolling 698...
Moderna (MRNA) Set to Announce Earnings on Thursday
ETF DAILY NEWS· 1 day agoModerna (NASDAQ:MRNA – Get Free Report) will be releasing its earnings data before the market opens on Thursday, May 2nd. Analysts expect Moderna to post earnings of ($3.36 ...